Market Closed -
Nyse
16:00:02 2024-06-17 EDT
|
5-day change
|
1st Jan Change
|
173.1
USD
|
+1.82%
|
|
-0.66%
|
-18.89%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,917
|
4,518
|
4,130
|
2,993
|
3,838
|
3,114
|
-
|
-
|
Enterprise Value (EV)
1 |
3,715
|
5,225
|
4,130
|
2,993
|
4,399
|
3,114
|
3,114
|
3,114
|
P/E ratio
|
79.1
x
|
114
x
|
34.1
x
|
-188
x
|
34.1
x
|
20.5
x
|
17.5
x
|
-
|
Yield
|
0.93%
|
0.62%
|
0.7%
|
-
|
0.83%
|
1.05%
|
1.08%
|
-
|
Capitalization / Revenue
|
2.57
x
|
3.19
x
|
2.34
x
|
1.54
x
|
1.97
x
|
1.6
x
|
1.52
x
|
1.45
x
|
EV / Revenue
|
2.57
x
|
3.19
x
|
2.34
x
|
1.54
x
|
1.97
x
|
1.6
x
|
1.52
x
|
1.45
x
|
EV / EBITDA
|
16.9
x
|
20.4
x
|
15.1
x
|
11.6
x
|
12
x
|
9.09
x
|
8.41
x
|
7.8
x
|
EV / FCF
|
43.7
x
|
28.2
x
|
150
x
|
-
|
16
x
|
16.8
x
|
16.5
x
|
-
|
FCF Yield
|
2.29%
|
3.55%
|
0.67%
|
-
|
6.26%
|
5.95%
|
6.07%
|
-
|
Price to Book
|
2.01
x
|
3.43
x
|
2.98
x
|
-
|
2.77
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
17,732
|
17,832
|
17,894
|
17,932
|
17,985
|
17,990
|
-
|
-
|
Reference price
2 |
164.5
|
253.4
|
230.8
|
166.9
|
213.4
|
173.1
|
173.1
|
173.1
|
Announcement Date
|
3/2/20
|
2/25/21
|
2/24/22
|
2/23/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,134
|
1,418
|
1,761
|
1,944
|
1,953
|
1,952
|
2,042
|
2,142
|
EBITDA
1 |
173.1
|
222
|
274.1
|
257.2
|
320.4
|
342.4
|
370.3
|
399.4
|
EBIT
1 |
121.9
|
134
|
182.6
|
177.9
|
227.8
|
251.6
|
281.8
|
314.4
|
Operating Margin
|
10.76%
|
9.45%
|
10.37%
|
9.15%
|
11.66%
|
12.89%
|
13.8%
|
14.68%
|
Earnings before Tax (EBT)
1 |
28.9
|
27.14
|
147
|
7.118
|
153.1
|
208.3
|
242.1
|
276.3
|
Net income
1 |
31.62
|
39.66
|
121.4
|
-15.93
|
112.7
|
151.7
|
178.2
|
-
|
Net margin
|
2.79%
|
2.8%
|
6.89%
|
-0.82%
|
5.77%
|
7.77%
|
8.72%
|
-
|
EPS
2 |
2.080
|
2.220
|
6.770
|
-0.8900
|
6.260
|
8.460
|
9.905
|
-
|
Free Cash Flow
1 |
66.83
|
160.5
|
27.48
|
-
|
240.2
|
185.4
|
189
|
-
|
FCF margin
|
5.9%
|
11.32%
|
1.56%
|
-
|
12.3%
|
9.5%
|
9.25%
|
-
|
FCF Conversion (EBITDA)
|
38.6%
|
72.3%
|
10.02%
|
-
|
74.98%
|
54.14%
|
51.02%
|
-
|
FCF Conversion (Net income)
|
211.34%
|
404.68%
|
22.64%
|
-
|
213.06%
|
122.21%
|
106.06%
|
-
|
Dividend per Share
2 |
1.525
|
1.560
|
1.620
|
-
|
1.780
|
1.820
|
1.866
|
-
|
Announcement Date
|
3/2/20
|
2/25/21
|
2/24/22
|
2/23/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
447
|
474.2
|
492.4
|
492.2
|
484.8
|
500.1
|
495.4
|
490.6
|
467.1
|
469.8
|
492.6
|
500.9
|
485.9
|
496
|
511.2
|
EBITDA
1 |
60.74
|
60.44
|
58.49
|
70.29
|
67.92
|
78.79
|
80.24
|
84.38
|
76.96
|
83.28
|
86.65
|
90.92
|
82.84
|
87.62
|
94.88
|
EBIT
1 |
39.33
|
39.16
|
38.8
|
50.94
|
48.98
|
56.29
|
58.76
|
61.84
|
50.88
|
59.24
|
64.46
|
68.58
|
60.39
|
65.17
|
71.63
|
Operating Margin
|
8.8%
|
8.26%
|
7.88%
|
10.35%
|
10.1%
|
11.26%
|
11.86%
|
12.6%
|
10.89%
|
12.61%
|
13.09%
|
13.69%
|
12.43%
|
13.14%
|
14.01%
|
Earnings before Tax (EBT)
1 |
24.65
|
21.85
|
17.01
|
36.3
|
-68.05
|
34.45
|
40.47
|
44.02
|
34.18
|
45.78
|
52.5
|
57.47
|
50.15
|
55
|
61.55
|
Net income
1 |
18.13
|
19.82
|
14.34
|
25.87
|
-75.96
|
29.53
|
29.35
|
33.67
|
20.2
|
35.23
|
38
|
42.2
|
36.3
|
41.05
|
45.75
|
Net margin
|
4.05%
|
4.18%
|
2.91%
|
5.26%
|
-15.67%
|
5.91%
|
5.92%
|
6.86%
|
4.32%
|
7.5%
|
7.71%
|
8.43%
|
7.47%
|
8.28%
|
8.95%
|
EPS
2 |
1.010
|
1.110
|
0.8000
|
1.440
|
-4.240
|
1.640
|
1.630
|
1.870
|
1.120
|
1.960
|
2.120
|
2.350
|
2.020
|
2.280
|
2.545
|
Dividend per Share
2 |
0.4150
|
0.4150
|
0.4150
|
0.4350
|
-
|
0.2100
|
0.4350
|
-
|
0.4550
|
-
|
0.4600
|
0.4600
|
0.4600
|
0.4600
|
0.4600
|
Announcement Date
|
2/24/22
|
5/5/22
|
8/4/22
|
11/3/22
|
2/23/23
|
5/4/23
|
8/1/23
|
11/2/23
|
2/29/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
797
|
706
|
-
|
-
|
561
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.605
x
|
3.181
x
|
-
|
-
|
1.751
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
66.8
|
160
|
27.5
|
-
|
240
|
185
|
189
|
-
|
ROE (net income / shareholders' equity)
|
10.6%
|
6.65%
|
8.96%
|
-
|
8.47%
|
40.1%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
4.98%
|
2.97%
|
4.15%
|
-
|
4.07%
|
20.4%
|
-
|
-
|
Assets
1 |
634.5
|
1,337
|
2,924
|
-
|
2,768
|
742
|
-
|
-
|
Book Value Per Share
|
82.00
|
74.00
|
77.50
|
-
|
76.90
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-
|
12.20
|
3.440
|
-
|
15.50
|
15.70
|
16.90
|
25.50
|
Capex
1 |
15.5
|
17.9
|
21.5
|
-
|
38.8
|
36
|
40.2
|
42.6
|
Capex / Sales
|
1.37%
|
1.26%
|
1.22%
|
-
|
1.99%
|
1.84%
|
1.97%
|
1.99%
|
Announcement Date
|
3/2/20
|
2/25/21
|
2/24/22
|
2/23/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
173.1
USD Average target price
232
USD Spread / Average Target +34.02% Consensus |
1st Jan change
|
Capi.
|
---|
| -18.89% | 3.11B | | +1.28% | 99.16B | | -10.90% | 58.77B | | +63.33% | 45.24B | | +11.62% | 37.1B | | -1.19% | 30.59B | | +7.44% | 19.33B | | +10.36% | 16.43B | | +4.78% | 13.39B | | -7.15% | 12.68B |
Other Commodity Chemicals
|